CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 21 enrolled
Drug / intervention
GRASP HEP +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03872466
NCT03872466N/ACompleted
CompareCT.gov

Glove Rehabilitation Application for Stroke Patients (GRASP)

Barron Associates, Inc.·interventional·Posted Mar 13, 2019·Updated Mar 25, 2025

In Brief

A clinical study evaluating GRASP HEP and Usual Care Treatment (UCT) for Occupational Therapy and Virtual Reality. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The University of Virginia (UVA) Director of Neurorehabilitation will lead GRASP randomized, controlled efficacy trials. The study will involve employment of the GRASP system in three one-hour sessions per week over eight weeks by stroke survivors suffering from ongoing hand function impairment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOccupational Therapy, Virtual Reality
CountriesUnited States
CollaboratorsUniversity of Virginia

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 13, 2019
Enrollment StartJun 11, 2020
Primary CompletionApr 26, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.3 years ago

Interventions

GRASP HEPdevice

The GRASP system comprises a sensor package and therapy game software that works with a commercial glove orthosis to enable virtual world-based practice of activities of daily living (ADLs) involving the hand.

Usual Care Treatment (UCT)behavioral

Participants in the control group will continue to receive any previously prescribed therapy services. These patients will not receive any treatment services through the study as UCT group participants.